Co-investment
Deals of The Day — Mergers and Acquisitions
The following bids, mergers, acquisitions and disposals were reported on Wednesday. The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday: Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.
Biogen's Purchase of Multiple Sclerosis Drug Ends Rocky Partnership with Elan
Biogen Idec agreement to buy Elan Corp's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious.
Nexstar Broadcasting Announces Secondary Stock Offering
Nexstar Broadcasting Group announces secondary offering of common stock by selling stockholders Nexstar Broadcasting Group, Inc. (NASDAQ: NXST) today announced that selling stockholders, funds affiliated with ABRY Partners, LLC, intend to offer 3.
Moscow bourse aims to raise $500 million in IPO
Moscow's stock exchange will be valued at up to $4.6 billion in its planned stock market flotation